SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and ...

RADNOR, Pa. and SOMERSET, N.J., Jan. 9, 2023 /PRNewswire/ -- Avantor, Inc. (AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced ...

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced preliminary financial ...

Catalent, Inc. CTLT is well-poised for growth in the coming quarters, courtesy of its product and service launches over the past few months. The optimism led by a solid fourth-quarter fiscal 2023 ...

Good morning, everyone. And thank you for joining us today to review Catalent’s fourth quarter 2023 financial results. Joining me on the call are John Greisch, Executive Chair of the Board; Alessandro ...

Catalent Inc (NYSE:CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management. The board has recommended and approved the appointment of four new ...

Elliott Investment Management L.p. Aug 29 (Reuters) - (This August 28 story has been refiled to correct the spelling of Elliott in the headline) Catalent Inc (CTLT.N), opens new tab is close to ...

Investors eyeing a purchase of Catalent Inc (Symbol: CTLT) stock, but tentative about paying the going market price of $59.14/share, might benefit from considering selling puts among the alternative ...

Shares of Catalent Inc. CTLT jumped 4.1% in premarket trading Tuesday, after the maker of products used by drug makers and consumer health companies announced a cooperation agreement with activist ...

Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases GelMEDIX Inc., a biotechnology company ...

Catalent, Inc. CTLT is well poised for growth in the coming quarters, backed by its robust facility expansion activities over the past few months. A robust first-quarter fiscal 2022 performance, along ...